B, W., M, S., J, C., S, A., SS, J., VM, N., . . . JT, B. (2025). Overcoming resistance in advanced urothelial carcinoma: Mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition. Frontiers in oncology, 15, 1654771. https://doi.org/10.3389/fonc.2025.1654771
Chicago Style (17th ed.) CitationB, Wummer, Schwartz M, Ciuro J, Ahmed S, Joshi SS, Narayan VM, Carthon BC, Bilen MA, and Brown JT. "Overcoming Resistance in Advanced Urothelial Carcinoma: Mechanisms of Escape from Antibody-drug Conjugates and FGFR3 Inhibition." Frontiers in Oncology 15 (2025): 1654771. https://doi.org/10.3389/fonc.2025.1654771.
MLA (9th ed.) CitationB, Wummer, et al. "Overcoming Resistance in Advanced Urothelial Carcinoma: Mechanisms of Escape from Antibody-drug Conjugates and FGFR3 Inhibition." Frontiers in Oncology, vol. 15, 2025, p. 1654771, https://doi.org/10.3389/fonc.2025.1654771.